Ha habido 46 transacciones internas recientes registradas para Spyre Therapeutics, Inc. (SYRE), incluyendo 28 compras y 16 ventas. El total de compras internas fue valorado en $70.86M y el total de ventas internas en $8.01M.
Internos destacados con actividad reciente incluyen Turtle Cameron, Burrows Scott L, Sloan Sheldon. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — SYRE
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2026-04-01 |
Turtle Cameron |
Chief Executive Officer |
Venta Informativa |
2,656 |
$49.92 |
$132.59K |
627,540 |
| 2026-04-01 |
Burrows Scott L |
Chief Financial Officer |
Venta Informativa |
1,300 |
$49.98 |
$64.97K |
97,994 |
| 2026-04-01 |
Sloan Sheldon |
Chief Medical Officer |
Venta Informativa |
7,958 |
$50.00 |
$397.9K |
- |
| 2026-03-03 |
Burrows Scott L |
Chief Financial Officer |
Venta Informativa |
200 |
$41.66 |
$8.33K |
97,994 |
| 2026-03-02 |
Turtle Cameron |
Chief Executive Officer |
Venta Informativa |
9,100 |
$42.49 |
$386.66K |
642,540 |
| 2026-02-02 |
Turtle Cameron |
Chief Executive Officer |
Venta Informativa |
14,043 |
$32.87 |
$461.59K |
657,540 |
| 2026-01-21 |
Henderson Michael Thomas |
Director |
Otro (Compra) |
63,227 |
- |
- |
168,606 |
| 2026-01-09 |
Turtle Cameron |
Chief Executive Officer |
Concesión de RSU |
528,000 |
$30.61 |
$16.16M |
528,000 |
| 2026-01-09 |
King-jones Heidy |
See Remarks |
Concesión de RSU |
140,000 |
$30.61 |
$4.29M |
140,000 |
| 2026-01-09 |
Burrows Scott L |
Chief Financial Officer |
Concesión de RSU |
140,000 |
$30.61 |
$4.29M |
140,000 |
| 2026-01-09 |
Sloan Sheldon |
Chief Medical Officer |
Concesión de RSU |
140,000 |
$30.61 |
$4.29M |
140,000 |
| 2026-01-02 |
Turtle Cameron |
Chief Executive Officer |
Venta Informativa |
100 |
$32.39 |
$3.24K |
671,907 |
| 2025-12-01 |
Turtle Cameron |
Chief Executive Officer |
Venta Informativa |
4,005 |
$29.83 |
$119.47K |
686,907 |
| 2025-11-03 |
Turtle Cameron |
Chief Executive Officer |
Venta Informativa |
16,845 |
$23.66 |
$398.55K |
701,907 |
| 2025-09-02 |
Burrows Scott L |
Chief Financial Officer |
Venta Informativa |
18,428 |
$16.26 |
$299.64K |
97,994 |
| 2025-05-29 |
Albers Jeffrey W. |
Director |
Concesión de RSU |
25,000 |
$15.55 |
$388.75K |
25,000 |
| 2025-05-29 |
Stelzer Laurie |
Director |
Concesión de RSU |
25,000 |
$15.55 |
$388.75K |
25,000 |
| 2025-05-29 |
Mckenna Mark C. |
Director |
Concesión de RSU |
25,000 |
$15.55 |
$388.75K |
25,000 |
| 2025-05-29 |
Henderson Michael Thomas |
Director |
Concesión de RSU |
25,000 |
$15.55 |
$388.75K |
25,000 |
| 2025-05-29 |
Fairmount Funds Management Llc |
Director |
Concesión de RSU |
25,000 |
$15.55 |
$388.75K |
25,000 |
| 2025-05-29 |
Milligan Sandra |
Director |
Concesión de RSU |
25,000 |
$15.55 |
$388.75K |
25,000 |
| 2025-01-15 |
Turtle Cameron |
Chief Executive Officer |
Concesión de RSU |
370,000 |
$21.66 |
$8.01M |
370,000 |
| 2025-01-15 |
King-jones Heidy |
See Remarks |
Concesión de RSU |
95,500 |
$21.66 |
$2.07M |
95,500 |
| 2025-01-15 |
Burrows Scott L |
Chief Financial Officer |
Concesión de RSU |
95,500 |
$21.66 |
$2.07M |
95,500 |
| 2025-01-15 |
Sloan Sheldon |
Chief Medical Officer |
Concesión de RSU |
95,500 |
$21.66 |
$2.07M |
95,500 |
| 2025-01-10 |
Henderson Michael Thomas |
Director |
Otro (Compra) |
105,379 |
- |
- |
105,379 |
| 2024-11-06 |
Albers Jeffrey W. |
Director |
Venta Informativa |
6,700 |
$36.76 |
$246.31K |
27,360 |
| 2024-10-25 |
Albers Jeffrey W. |
Director |
Venta Informativa |
300 |
$36.43 |
$10.93K |
34,060 |
| 2024-10-01 |
Sloan Sheldon |
Officer |
Desconocido |
- |
- |
- |
- |
| 2024-10-01 |
Sloan Sheldon |
Chief Medical Officer |
Concesión de RSU |
400,000 |
$27.46 |
$10.98M |
400,000 |
| 2024-09-03 |
Burrows Scott L |
Chief Financial Officer |
Venta Informativa |
18,531 |
$28.17 |
$522.07K |
116,422 |
| 2024-05-14 |
Albers Jeffrey W. |
Director |
Concesión de RSU |
11,323 |
$39.29 |
$444.88K |
11,323 |
| 2024-05-14 |
Stelzer Laurie |
Director |
Concesión de RSU |
11,323 |
$39.29 |
$444.88K |
11,323 |
| 2024-05-14 |
Henderson Michael Thomas |
Director |
Concesión de RSU |
11,323 |
$39.29 |
$444.88K |
11,323 |
| 2024-05-14 |
Fairmount Funds Management Llc |
Director |
Concesión de RSU |
11,323 |
$39.29 |
$444.88K |
11,323 |
| 2024-05-14 |
Milligan Sandra |
Officer |
Desconocido |
- |
- |
- |
- |
| 2024-05-14 |
Milligan Sandra |
Director |
Concesión de RSU |
21,980 |
$39.29 |
$863.59K |
21,980 |
| 2024-04-25 |
Fairmount Funds Management Llc |
Director |
Ejercicio de Opciones (Venta) |
90,992 |
- |
- |
346,045 |
| 2024-02-15 |
Turtle Cameron |
Chief Executive Officer |
Concesión de RSU |
400 |
$9.82 |
$3.93K |
746,907 |
| 2024-02-01 |
Turtle Cameron |
Chief Executive Officer |
Concesión de RSU |
277,750 |
$25.86 |
$7.18M |
277,750 |
| 2024-02-01 |
King-jones Heidy |
See Remarks |
Concesión de RSU |
63,000 |
$25.86 |
$1.63M |
63,000 |
| 2024-02-01 |
Burrows Scott L |
Chief Financial Officer |
Concesión de RSU |
70,000 |
$25.86 |
$1.81M |
70,000 |
| 2024-02-01 |
Mckenna Mark C. |
Director |
Disposición |
477,000 |
$10.39 |
$4.96M |
- |
| 2024-02-01 |
Mckenna Mark C. |
Director |
Concesión de RSU |
40,000 |
$25.86 |
$1.03M |
40,000 |
| 2023-12-29 |
Fairmount Funds Management Llc |
10 Percent Owner |
Otro (Venta) |
3,435,480 |
- |
- |
- |
| 2023-12-07 |
Fairmount Funds Management Llc |
10 Percent Owner |
Concesión de RSU |
16,667 |
- |
- |
16,667 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
